Vimarsana
Biggest News Aggregation in the World

Page 3 - Andera Acto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andera Acto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andera Acto Today - Breaking & Trending Today

EQS-News: Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - Vimarsana News

EQS-News: Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension

EQS-News: Andera Partners / Key word(s): Financing Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension 10.01.2023 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Andera Partners invests in S...

EQS-News: Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group - Vimarsana News

EQS-News: Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group

EQS-News: Andera Partners / Key word(s): Financing Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members - Vimarsana News

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members

/PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today...

DGAP-News: Andera Partners strengthens its Life Sciences team with a new partner - Vimarsana News

DGAP-News: Andera Partners strengthens its Life Sciences team with a new partner

DGAP-News: Andera Partners / Key word(s): Personnel Andera Partners strengthens its Life Sciences team with a new partner 07.07.2022 / 10:15 The issuer is solely responsible for

ImCheck Closes Upsized EUR 96 Million (USD 103 Million) - Vimarsana News

ImCheck Closes Upsized EUR 96 Million (USD 103 Million)

Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trialsSeries C...